Stay updated on CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.

Latest updates to the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov page continues to show a 403 Forbidden error, with the displayed site revision changing from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check9 days agoChange DetectedThe footer revision label advanced from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the typical study record content with an access message. Core elements such as sponsor details, eligibility criteria, locations, and outcomes are no longer visible due to the error.SummaryDifference18%

- Check52 days agoChange DetectedRevision: v3.6.6 replaces v3.6.5 as the page's version marker, indicating a small update to the site's code or content management. No changes to the study details, eligibility criteria, or results are introduced.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.6.5 appears, replacing Revision: v3.6.4. This indicates a newer build of the page without changes to the study information.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision tag updated to v3.6.4 on the page, reflecting a deployment-level change from the previous revision.SummaryDifference0.1%

Stay in the know with updates to CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.